Since its introduction in 1992, the 340B Program has vastly altered the pharmacy landscape. In these very uncertain times, as we continue to grasp COVID-19’s longevity and...

The Future of 340B: An Alinea Expert's Perspective An Interview with Keith Chop | April 1, 2021The past year has been one unlike any other. As facilities are navigating new...

The Alinea Group is pleased to announce the addition of Tom DiPiro to their team of industry experts and thought leaders.  DiPiro brings value to Alinea’s diverse team with...

In October 2017, I was invited to participate in a trip of a lifetime: a medical mission to Dharapani, a rural village located in the Manang Valley of Nepal. Filled with eagerness, excitement, and a healthy bit of anxiety, I flew ten thousand miles across the globe to Nepal’s capital city of Kathmandu…

Once again, the 340B Coalition Summer Conference did not disappoint! The conference, held by 340B Health, brings together more than two-thousand stakeholders to our nation’s capital each year in an effort to share 340B best practices and discuss key legislative developments around the embattled drug regulatory program.

It has now been six years since HRSA first started conducting 340B audits on a regular basis. If you are reading this as a covered entity, you may have already undergone a 340B HRSA audit. For an unlucky few, you might even be a two-time winner. And for the rest of you who haven’t been through one…

Can you believe it? With 5 months into the new year, we are almost halfway through 2017 already! While postponement of the 340B “mega guidance” dominated headlines early in the year, there have been several noteworthy developments around the 340B program that should be heeded by covered…

With the Government Accountability Office’s (“GAO”) study of 340B contract pharmacies currently under way, covered entities should take this time to conduct a thorough review of their contract pharmacy arrangements to understand the key elements, financials, and governance associated with their current and pending contract pharmacy relationships. Building on recommendations…

There is no doubt that 2017 will be a year packed with healthcare changes and plenty of news as the Trump administration takes office. Alinea outlines 5 key developments on upcoming legislation and insights gained from Alinea’s direct experience providing 340B audit and advisory services…

On December 6, 2016, Ohio Medicaid, in conjunction with Mercer Government Human Services Consulting, held a stakeholder meeting to discuss changes to pharmacy payments for Medicaid patients in response to the Centers for Medicare and Medicaid Services’ (CMS) Covered Outpatient Drug Final Rule (view here). The live webinar, which largely focused…